MD-102 (MD Biopharm)

N/A

Report date: 2024/04/10 13:52:16
NME

Base Information

Drug NameMD-102 (MD Biopharm)
Drug Alias NameMD102 (MD Biopharm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-glutamine gamma-glutamyltransferase inhibitors
TargetsProtein-glutamine gamma-glutamyltransferase
Therapy Area/IndicationsFibrosisTriple Negative Breast NeoplasmsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMD Biolab Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMD Biolab Co Ltd
Inactive CompaniesN/A
Active IndicationsFibrosisTriple Negative Breast NeoplasmsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A